周三,生物技术公司Sana Biotechnology开启飙涨,截至发稿涨逾200%,盘初一度涨超300%!公司宣布1型糖尿病无免疫抑制剂胰岛细胞移植研究取得积极临床结果。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.